OneOncology's Commitment to Community Oncology
At the heart of community oncology is OneOncology, a dedicated physician-led platform aimed at enhancing independent oncology practices. This platform emphasizes collaboration among community oncologists to foster the advancement of hematology, leading to better outcomes for patients dealing with cancer.
Celebrated Research at ASH Annual Meeting
OneOncology is excited to announce that its partner practice investigators are set to showcase 26 impactful abstracts at the prestigious annual meeting of the American Society of Hematology (ASH). Their participation underscores the pivotal role community practices play in expanding scientific knowledge and improving treatment options for patients with hematologic disorders.
Highlighting Diverse Research Contributions
The partner practices, including notable contributors, will present a total of 26 oral and poster presentations. Each abstract reflects a wide array of innovative research within hematology, highlighting OneOncology's unwavering commitment to excellence in advancing cancer care. These contributions are vital for enhancing clinical trials and ensuring that groundbreaking cancer treatments remain accessible.
Leadership Insights on Innovation
"Our practice partner physician investigators are at the forefront of innovation in hematology," remarked Ian W. Flinn, MD, PhD, Chief Scientific Officer at OneOncology and leader of the OneOncology Research Network (OneR). His statement emphasizes the organization's dedication to scientific advancements aimed at improving patients' lives. The breadth of research being shared this year signifies a steadfast commitment to transforming healthcare practices within the hematology field.
Impact on Patient Care
The abstracts presented at ASH will not only serve to educate but will also aim to propel community practices’ clinical trials programs. OneOncology's role enhances access to cutting-edge cancer therapies, ensuring that patients receive high-quality care in their communities, close to home.
About OneOncology
OneOncology was established by community oncologists with a vision to improve the lives of cancer patients. The organization strives to maintain the independence of community practices while providing collaborative support in operational effectiveness, data analytics, and clinical innovation. The vast network includes over 1,300 providers caring for approximately 747,000 patients across 420 locations nationwide. OneOncology remains a beacon of community-focused cancer treatment solutions.
Frequently Asked Questions
What is OneOncology's mission?
OneOncology's mission is to improve the lives of cancer patients by enabling community oncology practices to thrive independently and enhancing patient access to local care.
How many presentations will OneOncology make at ASH?
OneOncology will showcase a total of 26 oral and poster presentations at the upcoming ASH Annual Meeting.
Who is Ian W. Flinn?
Ian W. Flinn, MD, PhD, is the Chief Scientific Officer at OneOncology, leading the organization's research endeavors.
What is the significance of ASH for OneOncology?
The American Society of Hematology (ASH) Annual Meeting serves as a crucial platform for OneOncology to present their latest research and innovations in hematology.
How does OneOncology support community practices?
OneOncology supports community practices through operational optimization, group purchasing, data analytics, and clinical innovation to enhance patient care quality.
